227 related articles for article (PubMed ID: 10980054)
21. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
22. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure.
Ryo K; Kamogawa Y; Ikeda I; Yamauchi K; Yonehara S; Nagata S; Hayashi N
Am J Gastroenterol; 2000 Aug; 95(8):2047-55. PubMed ID: 10950056
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C.
Hiramatsu N; Hayashi N; Katayama K; Mochizuki K; Kawanishi Y; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1994 Jun; 19(6):1354-9. PubMed ID: 7514559
[TBL] [Abstract][Full Text] [Related]
24. Liver transplantation for acute or chronic liver failure by hepatitis non-A, non-B and hepatitis C viral infections: a postoperative follow-up.
Arnold JC; Kraus T; Otto G; Müller HM; Hofmann W; Gmelin K; Goeser T; Kommerell B; Theilmann L
Z Gastroenterol; 1992 Aug; 30(8):525-8. PubMed ID: 1329365
[TBL] [Abstract][Full Text] [Related]
25. HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice?
Jain A; Menegus M; Mohanka R; Orloff M; Abt P; Mantry P; Bozorgzadeh A
Exp Clin Transplant; 2006 Jun; 4(1):475-80. PubMed ID: 16827647
[TBL] [Abstract][Full Text] [Related]
26. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
[TBL] [Abstract][Full Text] [Related]
27. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.
Guerrero RB; Batts KP; Burgart LJ; Barrett SL; Germer JJ; Poterucha JJ; Wiesner RH; Charlton MR; Persing DH
Mod Pathol; 2000 Mar; 13(3):229-37. PubMed ID: 10757333
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication.
Berg T; Müller AR; Platz KP; Höhne M; Bechstein WO; Hopf U; Wiedenmann B; Neuhaus P; Schreier E
Hepatology; 1999 Jan; 29(1):245-9. PubMed ID: 9862873
[TBL] [Abstract][Full Text] [Related]
29. Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.
Macias J; Japón MA; Sáez C; Palacios RB; Mira JA; García-García JA; Merchante N; Vergara S; Lozano F; Gómez-Mateos J; Pineda JA
J Infect Dis; 2005 Nov; 192(9):1566-76. PubMed ID: 16206071
[TBL] [Abstract][Full Text] [Related]
30. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features.
Gretch DR; Bacchi CE; Corey L; dela Rosa C; Lesniewski RR; Kowdley K; Gown A; Frank I; Perkins JD; Carithers RL
Hepatology; 1995 Jul; 22(1):1-9. PubMed ID: 7601397
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
[TBL] [Abstract][Full Text] [Related]
32. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C.
Grassi A; Quarneti C; Ravaioli M; Bianchini F; Susca M; D'Errico A; Piscaglia F; Tamè MR; Andreone P; Grazi G; Galli S; Zauli D; Pinna AD; Bianchi FB; Ballardini G
Liver Transpl; 2006 Nov; 12(11):1673-81. PubMed ID: 17031825
[TBL] [Abstract][Full Text] [Related]
33. Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.
Ballardini G; De Raffele E; Groff P; Bioulac-Sage P; Grassi A; Ghetti S; Susca M; Strazzabosco M; Bellusci R; Iemmolo RM; Grazi G; Zauli D; Cavallari A; Bianchi FB
Liver Transpl; 2002 Jan; 8(1):10-20. PubMed ID: 11799480
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
Arenas JI; Gallegos-Orozco JF; Laskus T; Wilkinson J; Khatib A; Fasola C; Adair D; Radkowski M; Kibler KV; Nowicki M; Douglas D; Williams J; Netto G; Mulligan D; Klintmalm G; Rakela J; Vargas HE
J Infect Dis; 2004 Jun; 189(11):2037-46. PubMed ID: 15143471
[TBL] [Abstract][Full Text] [Related]
35. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
[TBL] [Abstract][Full Text] [Related]
36. Study on relationship between the apoptosis of hepatocytes and liver fibrosis of chronic viral hepatitis.
Xin S; Zhao J; Wang L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):31-3. PubMed ID: 11503021
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.
Schirren CA; Jung MC; Worzfeld T; Mamin M; Baretton G; Gerlach JT; Gruener NH; Zachoval R; Houghton M; Rau HG; Pape GR
J Infect Dis; 2001 Apr; 183(8):1187-94. PubMed ID: 11262200
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis and hepatitis C virus infection in renal transplant recipients.
Delladetsima I; Psichogiou M; Alexandrou P; Nikolopoulos G; Revenas K; Hatzakis A; Boletis J
Am J Clin Pathol; 2008 May; 129(5):744-8. PubMed ID: 18426734
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of recurrent HCV infection after liver transplantation].
Ostojić R
Acta Med Croatica; 2005; 59(5):443-6. PubMed ID: 16381241
[TBL] [Abstract][Full Text] [Related]
40. The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.
Aguilar-Reina J; Ruiz-Ferrer M; Pizarro MA; Antiñolo G
J Viral Hepat; 2005 Nov; 12(6):568-73. PubMed ID: 16255757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
